Trial of Cannabis for Essential Tremor
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03805750
Recruitment Status : Recruiting
First Posted : January 16, 2019
Last Update Posted : May 29, 2020
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 16 participants
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Double-Blind, Cross-Over, Placebo- Controlled Efficacy and Tolerability Study of Oral Cannabidiol (CBD) and Tetrahydrocannabinol (THC) for Essential Tremor (ET).
Actual Study Start Date : January 22, 2019
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : December 2020